“…In this setting, prescribing physicians cannot base their clinical target volume (CTV) on the anatomical borders of a defined structure, but must rely on experience and published contouring atlases to determine regions at risk for microscopic disease, possibly increasing variation in treatment volume delineation [12][13][14][15]. Several atlases have been published, but in the critical comprehensive review of post-prostatectomy guidelines and atlases, Smith and Rodrigues [16] concluded that the clinical impact and reproducibility have not been clearly assessed.…”